acemannan has been researched along with cyclin d1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, CH; Fu, TT; Guo, W; Huang, H; Li, XY; Li, Z; Qi, JH; Song, J; Xiao, Y; Xing, W; Xu, X; Yuan, PS; Zhu, M; Zou, CH | 1 |
1 other study(ies) available for acemannan and cyclin d1
| Article | Year |
|---|---|
Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway.
Topics: Adjuvants, Immunologic; Animals; Cell Proliferation; Cells, Cultured; Cyclin D1; Male; Mannans; Mice; Mice, Inbred BALB C; Models, Animal; Oncogene Protein v-akt; Signal Transduction; TOR Serine-Threonine Kinases; Wound Healing | 2015 |